Breathe Well Live Well
|
AstraZeneca Symbicort shows similar safety profile as Budesonide for asthma
Pharmaceutical Business Review AstraZeneca has published a new study that demonstrates that Symbicort Inhalation Aerosol 320/9 µg twice daily has a safety profile similar to Budesonide pressurized metered-dose inhaler (pMDI) 320 µg twice daily for asthma. SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows … |
View full post on asthma – Google News
|
Five Prime strikes deal with GSK for asthma drug
San Francisco Business Times The collaboration will give GlaxoSmithKline exclusive access to therapeutic drugs developed by Five Prime for refractory asthma and chronic obstructive pulmonary disease. The deal will allow Five Prime to receive up to $30 million over the next four … Five Prime Therapeutics Announces Second Strategic Alliance With GlaxoSmithKline |
View full post on asthma – Google News
|
Targacept reports error in asthma study
Triad Business Journal Targacept disclosed an error in the analysis of a potential asthma treatment, but says the candidate still holds promise. Targacept said an error in the analysis of a drug it recently studied as a potential treatment for asthma affected the results, … Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of … Targacept Revises Results Of Exploratory Drug Study; Shares Slump Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987 |
View full post on asthma – Google News
|
Asthma and allergies aren't always disabilities
Business Management Daily by The HR Specialist: Texas Employment Law on April 1, 2012 9:00am Some employees claim they have asthma and allergies that are exacerbated by common workplace smells. That doesn't mean, however, that employers have to create an allergen-free … |
View full post on asthma – Google News
|
Research and Markets: Asthma – Pipeline Review, H1 2012
Business Wire (press release) Dublin – Research and Markets (http://www.researchandmarkets.com/research/11929672/asthma_pipeline) has announced the addition of Global Markets Direct's new report "Asthma – Pipeline Review, H1 2012" to their offering. Global Markets Direct's, 'Asthma … |
View full post on asthma – Google News
|
MediciNova completes enrollment in Phase II asthma trial
Pharmaceutical Business Review MediciNova has completed enrollment in its Phase II trial (MN-221-CL-007) evaluating the safety and efficacy of MN-221 for treatment of acute exacerbations of asthma. The randomized, double-blind trial enrolled a total of 176 asthma patients in the … MediciNova Completes Enrollment in Phase 2 MN-221 Trial Treating Patients … |
View full post on asthma – Google News
|
Aerocrine: BlueCross BlueShield of Florida Continues Trend, Retires Negative …
Business Wire (press release) We will be better able to identify patients who will respond to inhaled corticosteroids and even determine in whom we may be able to decrease the doses of asthma controller medications” Aerocrine AB (NASDAQ OMX NORDIC: AERO)(STO:AEROB) announces that … |
View full post on asthma – Google News
 Cambridge First |
Asthma inhaler technology to save lives
Business Weekly A new inhaler training device incorporating sensor and wireless technology has been created by Cambridge Consultants to help save lives amid an asthma upsurge. Trials have shown that the simple, new T-Haler training device more than doubles patient … Inhaler trainer is a breeze |
View full post on asthma – Google News
|
Asthmatic fired after creating his own accommodation
Business Management Daily Kendall Nichols, who suffers from asthma, was working in a warehouse run by Charlotte-based Insource Performance Solutions when he was asked to conduct an inventory. The warehouse was hot, some of the inventory was stacked high and Nichols feared … |
View full post on asthma – Google News
|
New Book About Asthma Released by Dr. Gary Epler
Business Wire (press release) BOSTON–(BUSINESS WIRE)–World-renowned Harvard Medical School pulmonary and critical care consultant Dr. Gary Epler extends his critically-acclaimed five-step method for personalized health to asthma with his new book, Asthma: You're the Boss. |
View full post on asthma – Google News